Ann: Factor Therapeutics Appoints Transaction Advisor, page-10

Special price for special people who are long term suffering shareholders would only be fair.  Unfortunately am viewing this on new page and my pricing is correct  so I have missed that opportunity to sell a future or half mill.

What do you know of TC and experience in closing deals?   Just a tactic or trying to keep control of transaction and extract more value or a fools journey by management unable to engage a known advisor on decent terms because they think they have goods and bidders will line up?

Anything out of the ordinary rarely bodes well but there may be other international transnational support that TC has access to that we are not aware of?